Join to View Full Profile
UCSD School of Medicine9500 Gilman DrLa Jolla, CA 92093
Phone+1 858-822-2808
Fax+1 619-543-6614
Dr. Reed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1979 - 1984
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1978 - 1979
Harvard Medical SchoolClass of 1978- University of California (San Diego) Medical CenterFellowship, Infectious Disease
Certifications & Licensure
CA State Medical License 1979 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsChagas Disease Diagnostic Practices at Four Major Hospital Systems in California and Texas.Emily A Kelly, Jose I Echeverri Alegre, Katherine Promer, Jesica Hayon, Roumen Iordanov
The Journal of Infectious Diseases. 2024-01-12 - 54 citationsCommercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2.Raymond T. Suhandynata, Melissa A Hoffman, Deli Huang, Jenny Tuyet Tran, Michael J. Kelner
Clinical Chemistry. 2021-01-30 - 24 citationsMulti-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.Raymond T. Suhandynata, Melissa A Hoffman, Michael J. Kelner, Ronald W. McLawhon, Sharon L. Reed
The Journal of Applied Laboratory Medicine. 2020-11-01
Journal Articles
- Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium, San Diego: The Role of Antifungal Combination TherapyJeffrey D Jenks, Sharon L Reed, Sanjay R Mehta, International Journal of Antimicrobial Agents
Press Mentions
UC San Diego Partners with Diagnostics Manufacturers for COVID-19 Testing; Begins Trial to Assess Antiviral DrugMarch 28th, 2020
Grant Support
- Novel Therapeutics For Class B ProtozoaNational Institute Of Allergy And Infectious Diseases2008–2012
- Genetic Manipulation Of Entamoeba VirulenceNational Institute Of Allergy And Infectious Diseases2001–2005
- Interactions Of E Histolytica With Host Mucosal DefensesNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Protease Inhibitors--Novel Drug Therapy For T GondiiNational Institute Of Allergy And Infectious Diseases1998–2001
- Cysteine Proteinases And Virulence Of E. HistolyticaNational Institute Of Allergy And Infectious Diseases2000
- Cysteine Proteinases And Virulence Of E HistolyticaNational Institute Of Allergy And Infectious Diseases1995–1998
- Cysteine Proteinases And Virulence Of E. HistolyticaNational Institute Of Allergy And Infectious Diseases1990–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
